FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to gynecology, and can be used in differential diagnosis of functional hypothalamic amenorrhea (FHA) in women of reproductive age with underlying energy deficit and stress. For this purpose, women with FHA growth is measured, blood serum leptin is examined, adipose tissue is assessed by double-photon absorptiometry (DEXA). Based on the obtained data, calculating a differential index (DI) by original design formula. With value DI more than 21.4 predict high probability of presence of stress form in patient FHA. With value DI below 21.4 – FHA against background of energy deficiency.
EFFECT: method enables the most accurate diagnosis of the given pathology by detecting a leading pathogenetic development factor FHA.
1 cl, 3 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR SPECIFIC EATING DISORDER IN PATIENTS WITH SECONDARY OLIGOMENORRHEA | 2007 |
|
RU2386139C2 |
| METHOD FOR LOW BONE MINERAL DENSITY SCREENING IN FEMALES SUFFERING FROM SECONDARY AMENORRHEA | 2014 |
|
RU2548822C1 |
| METHOD OF CHOOSING THERAPEUTIC APPROACH IN MENSTRUAL DISORDERS IN ADOLESCENT GIRLS WITH OVERWEIGHT | 2010 |
|
RU2422824C1 |
| WAY OF FORECASTING OF RESTORATION OF MENSTRUAL FUNCTION AT PATIENTS WITH NERVOUS ANOREXIA | 2008 |
|
RU2363002C1 |
| METHOD FOR PREDICTION OF MENSTRUAL CYCLE RESTORATION FOR ADOLESCENT GIRLS WITH ANOREXIA NERVOSA | 2016 |
|
RU2627433C1 |
| METHOD OF FORECASTING THE RESTORATION OF MENSTRUAL FUNCTION IN WOMEN WITH AMENORRHEA ASSOCIATED WITH ANOREXIA NERVOSA | 2010 |
|
RU2442170C1 |
| METHOD FOR PREDICTION OF DEVELOPMENT OF OVARIAN DYSFUNCTION AND EVALUATION OF CLINICAL EFFECTIVENESS IN ADOLESCENT GIRLS SUFFERING FROM OBESITY | 2019 |
|
RU2743728C1 |
| METHOD FOR SELECTING THERAPEUTIC APPROACH TO FEMALE PATIENTS WITH OLIGOMENORRHEA AND OBESITY | 2014 |
|
RU2555347C1 |
| METHOD FOR PREDICTION OF MENSTRUAL RECOVERY IN ADOLESCENT GIRLS WITH NORMOGONADOTROPIC OLIGOMENORRHEA | 2020 |
|
RU2740848C1 |
| METHOD OF CORRECTING MENSTRUAL IRREGULARITIES IN WOMEN WITH METABOLIC SYNDROME | 2022 |
|
RU2813333C1 |
